Weiweiwei
Lv0
0 积分
2024-03-28 加入
-
Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study
30天前
已完结
-
Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
30天前
已完结
-
A Single-Arm, Phase II Study of the Anti-Blys Monoclonal Antibody Belimumab in Symptomatic Waldenstrom Macroglobulinemia
30天前
已完结
-
Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial
30天前
已完结
-
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
30天前
已完结
-
Sequential treatment of rituximab and belimumab in thrombotic thrombocytopenia purpura associated with systemic lupus erythematous: A respective case series and literature review
30天前
已完结
-
Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial
30天前
已完结
-
Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
30天前
已完结
-
Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome
30天前
已完结
-
EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
30天前
已完结